EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX: NIPH)

EGX: NIPH Revenue

EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of 121.77M EGP in the quarter ending September 30, 2024, a decrease of -67.85%. This brings the company's revenue in the last twelve months to 885.62M, down -23.16% year-over-year. In the fiscal year ending June 30, 2024, EI- Nile Co. for Pharmaceuticals and Chemical Industries had annual revenue of 1.14B with 13.67% growth.

• Revenue (ttm): 885.62M
• Revenue Growth: -23.16%
• P/S Ratio: 0.64
• Revenue / Employee: 354.25K
• Employees: 2,500
• Market Cap: 565.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.14B	137.37M	13.67%
Jun 30, 2023	1.01B	128.44M	14.65%
Jun 30, 2022	876.78M	121.27M	16.05%
Jun 30, 2021	755.51M	-57.02M	-7.02%
Jun 30, 2020	812.54M	174.26M	27.30%